In the recent publication, A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology, researchers examined published research using small animal irradiators, including SARRP. See more...
We are delighted to introduce the newest members of our radiation research division: Tim Devling and Levi Vaughan, who we welcome to the company working out of our UK office. Xstrahl has been committed to advancing research excellence for more than a decade,...
As new technologies increase the accuracy and clinical relevance of our delivery of radiotherapy to preclinical models of cancer, it becomes even more important that the preclinical models are also representative of the clinical scenario. There are limitations to...
In the recent study, Increased Relative Biological Effectiveness of Orthovoltage X-rays Compared to γ-rays in Preclinical Irradiation, researchers found that a dose reduction is necessary for X-rays to achieve comparable biological effects. See more below and the...
Xstrahl is proud to connect investigators from diverse audiences – including academic institutions, research hospitals, CROs, biotech and pharmaceutical companies, and countless interdisciplinary teams – to inspire science and advance care with successful preclinical...
In the recent study, Muscle-specific functional deficits and lifelong fibrosis in response to paediatric radiotherapy and tumour elimination, researchers investigated muscle fibrosis in pediatric cancer models. SARRP’s precise radiation delivery allowed researchers to...
In the recent publication, Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy, researchers examined treatment modalities to aid the development of PARP inhibitors. These compounds target tumors deficient in the Homologous Recombination...
In the study, Differential Effects of Radiation Fractionation Regimens on Glioblastoma, researchers compared radiation regimens for glioblastomas, and their radiotoxicity and neurocognitive effects. SARRP was used for in vivo and in vitro irradiation in the study. See...
We are thrilled to announce that MuriSuite, a brand new control system for all SARRP devices, will be released this year. Hear more in this video from our CEO, Adrian Treverton and our resident SARRP expert, Wilfried Goetz. https://vimeo.com/710478777
Contact Us